These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35339638)

  • 1. Reducing broad-spectrum antibiotic use in intensive care unit between first and second waves of COVID-19 did not adversely affect mortality.
    Chan XHS; O'Connor CJ; Martyn E; Clegg AJ; Choy BJK; Soares AL; Shulman R; Stone NRH; De S; Bitmead J; Hail L; Brealey D; Arulkumaran N; Singer M; Wilson APR
    J Hosp Infect; 2022 Jun; 124():37-46. PubMed ID: 35339638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set.
    Conway Morris A; Kohler K; De Corte T; Ercole A; De Grooth HJ; Elbers PWG; Povoa P; Morais R; Koulenti D; Jog S; Nielsen N; Jubb A; Cecconi M; De Waele J;
    Crit Care; 2022 Aug; 26(1):236. PubMed ID: 35922860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults.
    Vidaur L; Eguibar I; Olazabal A; Aseguinolaza M; Leizaola O; Guridi A; Iglesias MT; Rello J
    Eur J Intern Med; 2024 Jan; 119():93-98. PubMed ID: 37580243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
    Sathyakamala R; Peace AR; Shanmugam P
    J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre study.
    Salehi M; Khalili H; Seifi A; Davoudi H; Darazam IA; Jahangard-Rafsanjani Z; Mohammadnejad E; Heydari B; Siahkaly SJM; Tabarsi P; Kalantari S; Menshadi SAD; Babamahmoodi F; Khorvash F; Davarpanah MA; Soltani R; Yaghoobi MH; Anari SAM; Khodadadi J; Aliramezani A; Hantooshzadeh S; Naderi HR; Hajiabdolbaghi M; Elyasi S; Firouzabadi D; Kasgari HA; Roshanzamiri S; Ebrahimpour S
    J Clin Pharm Ther; 2022 Dec; 47(12):2140-2151. PubMed ID: 36054303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study.
    Crook P; Logan C; Mazzella A; Wake RM; Cusinato M; Yau T; Ong YE; Planche T; Basarab M; Bicanic T
    BMC Infect Dis; 2023 Nov; 23(1):808. PubMed ID: 37978457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
    Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.
    Mustafa ZU; Saleem MS; Ikram MN; Salman M; Butt SA; Khan S; Godman B; Seaton RA
    Pathog Glob Health; 2022 Oct; 116(7):421-427. PubMed ID: 34783630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit.
    Coloretti I; Farinelli C; Biagioni E; Gatto I; Munari E; Dall'Ara L; Busani S; Meschiari M; Tonelli R; Mussini C; Guaraldi G; Cossarizza A; Clini E; Girardis M;
    J Thorac Dis; 2023 Jun; 15(6):3218-3227. PubMed ID: 37426115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of characteristics, predictors and outcomes between the first and second COVID-19 waves in a tertiary care centre in Switzerland: an observational analysis.
    Wolfisberg S; Gregoriano C; Struja T; Kutz A; Koch D; Bernasconi L; Hammerer-Lercher A; Mohr C; Haubitz S; Conen A; Fux C; Mueller B; Schuetz P
    Swiss Med Wkly; 2021 Aug; 151():w20569. PubMed ID: 34375985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
    Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
    Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of patients with COVID-19 admitted to the intensive care unit during the first and second waves of the pandemic in Brazil: a single-center retrospective cohort study.
    Corrêa TD; Midega TD; Cordioli RL; Barbas CSV; Rabello Filho R; Silva BCD; Silva Júnior M; Nawa RK; Carvalho FRT; Matos GFJ; Lucinio NM; Rodrigues RD; Eid RAC; Bravim BA; Pereira AJ; Santos BFCD; Pinho JRR; Pardini A; Teich VD; Laselva CR; Cendoroglo Neto M; Klajner S; Ferraz LJR
    Einstein (Sao Paulo); 2023; 21():eAO0233. PubMed ID: 37493832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.